EAM
Erste Asset Management Portfolio holdings
AUM
$11.9B
1-Year Return
22.95%
This Quarter Return
+12.25%
1 Year Return
+22.95%
3 Year Return
+112.82%
5 Year Return
+205.55%
10 Year Return
–
AUM
$7.34B
AUM Growth
+$518M
(+7.6%)
Cap. Flow
-$17.9M
Cap. Flow
% of AUM
-0.24%
Top 10 Holdings %
Top 10 Hldgs %
23.18%
Holding
927
New
39
Increased
180
Reduced
133
Closed
52
Top Buys
| 1 |
AutoZone
AZO
|
+$50.4M |
| 2 |
Apple
AAPL
|
+$33.1M |
| 3 |
Masimo
MASI
|
+$16.9M |
| 4 |
NOVA
Sunnova Energy
NOVA
|
+$16.1M |
| 5 |
Pure Storage
PSTG
|
+$13M |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$52.8M |
| 2 |
Madrigal Pharmaceuticals
MDGL
|
+$19.8M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
+$18.9M |
| 4 |
Sarepta Therapeutics
SRPT
|
+$16.8M |
| 5 |
Texas Roadhouse
TXRH
|
+$16.6M |
Sector Composition
| 1 | Technology | 34.21% |
| 2 | Healthcare | 16.51% |
| 3 | Consumer Discretionary | 10.4% |
| 4 | Financials | 10.05% |
| 5 | Industrials | 9.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
Citizens Financial Group
CFG
$22.3B
| $1.59M | 0.02% |
44,428
+5,611
| +14% | +$201K |
|
327
T-Mobile US
TMUS
$273B
| $1.57M | 0.02% |
9,600
| – | – |
|
328
Invesco
IVZ
$9.91B
| $1.49M | 0.02% |
90,583
+11,393
| +14% | +$187K |
|
329
Immunovant
IMVT
$2.86B
| $1.48M | 0.02% |
45,500
| – | – |
|
330
Arcellx
ACLX
$4B
| $1.48M | 0.02% |
+21,000
| New | +$1.48M |
|
331
Colliers International
CIGI
$8.45B
| $1.48M | 0.02% |
12,000
+6,000
| +100% | +$739K |
|
332
DexCom
DXCM
$30.7B
| $1.46M | 0.02% |
10,488
-4,320
| -29% | -$602K |
|
333
Match Group
MTCH
$9.19B
| $1.41M | 0.02% |
39,409
+5,046
| +15% | +$181K |
|
334
FMC
FMC
$4.6B
| $1.41M | 0.02% |
22,550
| – | – |
|
|
DCBO
335
Docebo
DCBO
$890M
| $1.4M | 0.02% |
27,900
+5,000
| +22% | +$251K |
|
336
Amicus Therapeutics
FOLD
$2.43B
| $1.39M | 0.02% |
116,850
| – | – |
|
337
Flowserve
FLS
$7.22B
| $1.37M | 0.02% |
30,000
| – | – |
|
338
Weyerhaeuser
WY
$18.2B
| $1.37M | 0.02% |
38,000
| – | – |
|
339
Progyny
PGNY
$1.98B
| $1.35M | 0.02% |
35,528
+4,000
| +13% | +$152K |
|
340
Arrowhead Research
ARWR
$3.83B
| $1.35M | 0.02% |
+47,000
| New | +$1.35M |
|
341
Keros Therapeutics
KROS
$638M
| $1.34M | 0.02% |
20,700
+15,000
| +263% | +$970K |
|
342
Stride
LRN
$7.25B
| $1.34M | 0.02% |
21,100
| – | – |
|
343
Insmed
INSM
$31.1B
| $1.3M | 0.02% |
47,600
| – | – |
|
344
Verisk Analytics
VRSK
$37.5B
| $1.3M | 0.02% |
5,600
+1,400
| +33% | +$325K |
|
345
Laureate Education
LAUR
$4.06B
| $1.29M | 0.02% |
89,186
+25,000
| +39% | +$363K |
|
346
AvalonBay Communities
AVB
$27.8B
| $1.29M | 0.02% |
7,000
| – | – |
|
347
Canadian Natural Resources
CNQ
$64.3B
| $1.27M | 0.02% |
33,600
-400
| -1% | -$15.1K |
|
348
Public Storage
PSA
$50.9B
| $1.27M | 0.02% |
4,400
| – | – |
|
349
Extra Space Storage
EXR
$30.8B
| $1.25M | 0.02% |
8,500
| – | – |
|
350
Warner Bros
WBD
$30.4B
| $1.25M | 0.02% |
144,360
+18,913
| +15% | +$163K |
|